Search details
1.
The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world setting.
Diabetes Obes Metab
; 21(6): 1429-1436, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30768845
2.
Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis).
Diabetes Obes Metab
; 20(2): 448-452, 2018 02.
Article
in English
| MEDLINE | ID: mdl-28736942
3.
Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA.
Diabetes Obes Metab
; 19(8): 1155-1164, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28251792
4.
Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes: a double-blind extension of a Phase III randomized controlled trial.
Cardiovasc Diabetol
; 14: 154, 2015 Dec 23.
Article
in English
| MEDLINE | ID: mdl-26701110
5.
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial-Study Design and Protocol.
Diabetes Ther
; 15(6): 1461-1471, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38653903
6.
Prediction of Resuscitation for Pediatric Sepsis from Data Available at Triage.
AMIA Annu Symp Proc
; 2021: 1129-1138, 2021.
Article
in English
| MEDLINE | ID: mdl-35308977
7.
Validation of parsimonious prognostic models for patients infected with COVID-19.
BMJ Health Care Inform
; 28(1)2021 Sep.
Article
in English
| MEDLINE | ID: mdl-34479962
8.
Urinary NGAL marks cystic disease in HIV-associated nephropathy.
J Am Soc Nephrol
; 20(8): 1687-92, 2009 Aug.
Article
in English
| MEDLINE | ID: mdl-19628667
9.
Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice.
Diabetes Ther
; 11(2): 467-478, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31901115
10.
Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal-Bolus Insulin: Phase 4 OPTIMIZE Study.
Diabetes Ther
; 11(2): 495-507, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31925722
11.
Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score Matched Analysis.
Diabetes Ther
; 11(1): 305-318, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31848983
12.
A validated, real-time prediction model for favorable outcomes in hospitalized COVID-19 patients.
NPJ Digit Med
; 3: 130, 2020.
Article
in English
| MEDLINE | ID: mdl-33083565
13.
Quantitative coronary angiography in the current era: principles and applications.
J Interv Cardiol
; 22(6): 527-36, 2009 Dec.
Article
in English
| MEDLINE | ID: mdl-19627430
14.
Association of Patient Profile with Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL in Type 2 Diabetes: A Post Hoc Patient-Level Meta-Analysis.
Diabetes Ther
; 9(5): 2043-2053, 2018 Oct.
Article
in English
| MEDLINE | ID: mdl-30203238
15.
More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial.
Diabetes Care
; 41(10): 2147-2154, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30104294
16.
Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-World Setting: A Retrospective Observational Study.
Adv Ther
; 35(1): 43-55, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29313285
17.
The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type 2 diabetes: A patient-level meta-analysis of EDITION 2 and 3.
PLoS One
; 13(1): e0190579, 2018.
Article
in English
| MEDLINE | ID: mdl-29370218
18.
Late diabetes complications and non-dipping phenomenon in patients with Type 1 diabetes.
Diabetes Res Clin Pract
; 71(1): 14-20, 2006 Jan.
Article
in English
| MEDLINE | ID: mdl-15963594
19.
Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus.
Clin Ther
; 37(8): 1773-88.e1, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-26138864
20.
Pharmaceutical pricing, cost containment and new treatments for rare diseases in children.
Orphanet J Rare Dis
; 9: 152, 2014 Oct 28.
Article
in English
| MEDLINE | ID: mdl-25348640